These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27229097)

  • 1. A pancreatic cancer multidisciplinary clinic: insights and outcomes.
    Schiffman SC; Abberbock S; Winters S; Valko C; Steve J; Zureikat AH; Zeh HJ; Hogg ME
    J Surg Res; 2016 May; 202(2):246-52. PubMed ID: 27229097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary management of locally advanced pancreatic ductal adenocarcinoma.
    Alemi F; Alseidi A; Scott Helton W; Rocha FG
    Curr Probl Surg; 2015 Sep; 52(9):362-98. PubMed ID: 26363649
    [No Abstract]   [Full Text] [Related]  

  • 3. Neoadjuvant therapy is associated with a reduced lymph node ratio in patients with potentially resectable pancreatic cancer.
    Roland CL; Yang AD; Katz MH; Chatterjee D; Wang H; Lin H; Vauthey JN; Pisters PW; Varadhachary GR; Wolff RA; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Apr; 22(4):1168-75. PubMed ID: 25352267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic Cancer Multidisciplinary Clinic is Associated with Improved Treatment and Elimination of Socioeconomic Disparities.
    Hoehn RS; Zenati M; Rieser CJ; Stitt L; Winters S; Paniccia A; Zureikat AH
    Ann Surg Oncol; 2024 Mar; 31(3):1906-1915. PubMed ID: 37989957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronologic changes in clinical and survival features of pancreatic ductal adenocarcinoma since 2000: A single-center experience with 2,029 patients.
    Shin SH; Kim SC; Song KB; Hwang DW; Lee JH; Park KM; Lee YJ
    Surgery; 2018 Sep; 164(3):432-442. PubMed ID: 29884479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prognostic factors for long-term survival in patients with pancreatic ductal adenocarcinoma].
    Kawaida H; Fujii H
    Nihon Rinsho; 2015 Mar; 73 Suppl 3():181-5. PubMed ID: 25857011
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pancreatic cancer- a curable disease].
    Limani P; Samaras P; Lesurtel M; Graf R; DeOliveira ML; Petrowsky H; Clavien PA
    Praxis (Bern 1994); 2015 Apr; 104(9):453-60. PubMed ID: 25900693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of early disease progression and surgical complications on adjuvant chemotherapy completion rates and survival in patients undergoing the surgery first approach for resectable pancreatic ductal adenocarcinoma - A population-based cohort study.
    Labori KJ; Katz MH; Tzeng CW; Bjørnbeth BA; Cvancarova M; Edwin B; Kure EH; Eide TJ; Dueland S; Buanes T; Gladhaug IP
    Acta Oncol; 2016; 55(3):265-77. PubMed ID: 26213211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of nationwide enhanced implementation of best practices in pancreatic cancer care (PACAP-1): a multicenter stepped-wedge cluster randomized controlled trial.
    Mackay TM; Smits FJ; Latenstein AEJ; Bogte A; Bonsing BA; Bos H; Bosscha K; Brosens LAA; Hol L; Busch ORC; Creemers GJ; Curvers WL; den Dulk M; van Dieren S; van Driel LMJW; Festen S; van Geenen EJM; van der Geest LG; de Groot DJA; de Groot JWB; Haj Mohammad N; Haberkorn BCM; Haver JT; van der Harst E; Hemmink GJM; de Hingh IH; Hoge C; Homs MYV; van Huijgevoort NC; Jacobs MAJM; Kerver ED; Liem MSL; Los M; Lubbinge H; Luelmo SAC; de Meijer VE; Mekenkamp L; Molenaar IQ; van Oijen MGH; Patijn GA; Quispel R; van Rijssen LB; Römkens TEH; van Santvoort HC; Schreinemakers JMJ; Schut H; Seerden T; Stommel MWJ; Ten Tije AJ; Venneman NG; Verdonk RC; Verheij J; van Vilsteren FGI; de Vos-Geelen J; Vulink A; Wientjes C; Wit F; Wessels FJ; Zonderhuis B; van Werkhoven CH; van Hooft JE; van Eijck CHJ; Wilmink JW; van Laarhoven HWM; Besselink MG;
    Trials; 2020 Apr; 21(1):334. PubMed ID: 32299515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understaging of clinical stage I pancreatic cancer and the impact of multimodality therapy.
    Baugh KA; Tran Cao HS; van Buren G; Silberfein EJ; Hsu C; Chai C; Barakat O; Fisher WE; Massarweh NN
    Surgery; 2019 Feb; 165(2):307-314. PubMed ID: 30243481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic role of time to diagnosis and presenting symptoms in patients with pancreatic cancer.
    Gobbi PG; Bergonzi M; Comelli M; Villano L; Pozzoli D; Vanoli A; Dionigi P
    Cancer Epidemiol; 2013 Apr; 37(2):186-90. PubMed ID: 23369450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Follow-up after curative surgery for pancreatic ductal adenocarcinoma: asymptomatic recurrence is associated with improved survival.
    Nordby T; Hugenschmidt H; Fagerland MW; Ikdahl T; Buanes T; Labori KJ
    Eur J Surg Oncol; 2013 Jun; 39(6):559-66. PubMed ID: 23498362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary Clinics for Colorectal Cancer Care Reduces Treatment Time.
    Kozak VN; Khorana AA; Amarnath S; Glass KE; Kalady MF
    Clin Colorectal Cancer; 2017 Dec; 16(4):366-371. PubMed ID: 28527628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Pancreatic Cancer Multidisciplinary Clinic Eliminates Socioeconomic Disparities in Treatment and Improves Survival.
    Hoehn RS; Rieser CJ; Winters S; Stitt L; Hogg ME; Bartlett DL; Lee KK; Paniccia A; Ohr JP; Gorantla VC; Krishnamurthy A; Rhee JC; Bahary N; Olson AC; Burton S; Ellsworth SG; Slivka A; McGrath K; Khalid A; Fasanella K; Chennat J; Brand RE; Das R; Sarkaria R; Singhi AD; Zeh HJ; Zureikat AH
    Ann Surg Oncol; 2021 May; 28(5):2438-2446. PubMed ID: 33523364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.
    Takahashi S; Kinoshita T; Konishi M; Gotohda N; Kato Y; Kinoshita T; Kobayashi T; Mitsunaga S; Nakachi K; Ikeda M
    J Hepatobiliary Pancreat Sci; 2011 Jul; 18(4):567-74. PubMed ID: 21331805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low total lymphocyte count is associated with poor survival in patients with resected pancreatic adenocarcinoma receiving a GM-CSF secreting pancreatic tumor vaccine.
    Schueneman AJ; Sugar EA; Uram J; Bigelow E; Herman JM; Edil BH; Jaffee EM; Zheng L; Laheru DA
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3(0 3):S725-30. PubMed ID: 24046118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume.
    Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS
    Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A modified Dworak classification applied to pancreatic adenocarcinoma: a useful prognostic factor].
    Turrini O; Viret F; Moureau L; Guiramand J; Lelong B; Bège T; Giovannini M; Delpero JR
    Bull Cancer; 2007 Oct; 94(10):897-901. PubMed ID: 17964983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Addition of Postoperative Chemotherapy is Associated with Improved Survival in Patients with Pancreatic Cancer Treated with Preoperative Therapy.
    Roland CL; Katz MH; Tzeng CW; Lin H; Varadhachary GR; Shroff R; Javle M; Fogelman D; Wolff RA; Vauthey JN; Crane CH; Lee JE; Fleming JB
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3(Suppl 3):S1221-8. PubMed ID: 26350371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma.
    Grossberg AJ; Chu LC; Deig CR; Fishman EK; Hwang WL; Maitra A; Marks DL; Mehta A; Nabavizadeh N; Simeone DM; Weekes CD; Thomas CR
    CA Cancer J Clin; 2020 Sep; 70(5):375-403. PubMed ID: 32683683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.